Special Issue "Epigenetic DNA Modifications as Cancer Biomarkers"
Deadline for manuscript submissions: closed (30 September 2018).
Epigenetic changes in cancer tissues, and their surrounding environments, have been often-reported in recent years. There may be a temptation to view such changes as little more than mechanistic regulators of gene expression, but they can also be biomarkers in the broadest sense of the word.
Modifications, such as DNA methylation, have a role to play in processes, such as:
- defining sub-classes of disease at a molecular level,
- providing targets for liquid biopsies or in-situ imaging,
- physical markers of cell turnover and chromatin accessibility,
- elucidating the life-history of disease,
- and clarifying the interpretation of somatic mutation signatures in DNA
In addition, through regulation of transcription they can explain the biology behind many aspects of gene-expression-based biomarkers and counsel as to the bounds at which those biomarkers cease to be useful. Or through competition for metabolic resources they can inform about processes that are often at the heart of cancer biology.
This Special Issue is focused on studies relating to epigenetic DNA modifications in cancer, and in particular their use to make inference about other aspects of the disease, whether prognostic, retrospective or diagnostic.
We invite potential authors working actively in these fields to submit their original research, software, or review manuscripts. Papers making use of pre-existing data to gain new insights into cancer are particularly welcome.Dr. Andy Lynch
Dr. Charlie Massie
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- DNA methylation
- liquid biopsy